When considering the similar osmotic diuresis effects of acetazolamide and SGLT2 inhibitors in the proximal tubule, it is well known SGLT2 inhibitors display benefits in the management of heart failure in long term management. This evidence concerns the gene SLC5A2 and heart failure.